
BETd-246
CAS No. 2140289-17-2
BETd-246( BETd 246 | BETd246 )
Catalog No. M13420 CAS No. 2140289-17-2
A potent, second-generation BET protein degrader that exhibits superior selectivity, potency and antitumor activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 485 | Get Quote |
![]() ![]() |
10MG | 710 | Get Quote |
![]() ![]() |
25MG | 1449 | Get Quote |
![]() ![]() |
50MG | 2196 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBETd-246
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, second-generation BET protein degrader that exhibits superior selectivity, potency and antitumor activity.
-
DescriptionA potent, second-generation BET protein degrader that exhibits superior selectivity, potency and antitumor activity; completely and selectively depletes BRD2, BRD3 and BRD4 in representative TNBC cell lines with 30-100 nM for 1 h or with 10-30 nM for 3 h incubation; displays strong growth inhibition and apoptosis induction activity in TNBC cell lines with IC50 <1 uM, induces a rapid and time-dependent downregulation of MCL1 protein; decreases BET proteins in xenograft breast tumors and suppress tumor growth in vivo without causing weight loss.
-
In VitroBETd-246 treatment (0-100 nM, 1-3 h) causes a dose-dependent depletion of BRD2, BRD3 and BRD4 in representative TNBC cell lines with 30-100 nM for 1 h or with 10-30 nM for 3 h incubation. BETd-246 (100 nM, 24/48 hours) displays strong growth inhibition and apoptosis induction activity in MDA-MB-468 cell lines. BETd-246 induces a rapid and time-dependent downregulation of MCL1 protein in all the TNBC cell lines evaluated. BETd-246 induces much stronger apoptosis than BETi-211.BETd-246 (100 nM, 24 hours) induces pronounced cell cycle arrest and apoptosis in TNBC cell lines. Cell Proliferation Assay Cell Line:MDA-MB-468 cells Concentration:100 nM Incubation Time:24 or 48 hours Result:Displayed strong growth inhibition and apoptosis induction activity in TNBC cell lines.Cell Cycle Analysis Cell Line:Human TNBC cells Concentration:100 nM Incubation Time:24 hours Result:Induced pronounced cell cycle arrest and apoptosis in TNBC cell lines.Western Blot Analysis Cell Line:Human TNBC cells Concentration:0-100 nM Incubation Time:1-3 hours Result:Caused a dose-dependent depletion of BRD2, BRD3 and BRD4.
-
In VivoBETd-246 (5 mg/kg, IV, 3 times per week for 3 weeks) treatment effectively inhibits WHIM24 tumor growth, similar to the antitumor activity of BETi-211 with higher dosage and more frequently administration. The treatment of 10 mg/kg induces partial tumor regression during treatment without apparent toxicity. BETd-246 has very limited drug exposure in the xenograft tumor tissue in MDA-M-231and MDA-MB-468 models. Animal Model:“Washington Human in Mouse (WHIM)” (PDX) model developed from a patient with treatment-resistant breast cancer (ESRE380Q, PR- and HER2-)).Dosage:5, 10 mg/kg Administration:IV, 3 times per week for 3 weeks.Result:Effectively inhibited WHIM24 tumor growth.
-
SynonymsBETd 246 | BETd246
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPROTAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2140289-17-2
-
Formula Weight946.035
-
Molecular FormulaC48H55N11O10
-
Purity>98% (HPLC)
-
SolubilityDMSO : 200 mg/mL 211.41 mM
-
SMILESCCN1C(=CC(=N1)C2CC2)NC3=NC(=NC4=C3C5=CC(=C(C=C5N4)C6=C(ON=C6C)C)OC)C(=O)NCCCOCCOCCOCCCNC7=CC=CC8=C7C(=O)N(C8=O)C9CCC(=O)NC9=O
-
Chemical Name4-((3-cyclopropyl-1-ethyl-1H-pyrazol-5-yl)amino)-7-(3,5-dimethylisoxazol-4-yl)-N-(3-(2-(2-(3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)propoxy)ethoxy)ethoxy)propyl)-6-methoxy-9H-pyrimido[4,5-b]indole-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bai L, et al. Cancer Res. 2017 May 1;77(9):2476-2487.
molnova catalog



related products
-
CDK9-PROTAC
CDK9-PROTAC is a heterobifunctional small molecule PROTAC capable of cereblon mediated proteasomal degradation of CDK9.
-
Azido-PEG1-azide
Azido-PEG1-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Hexane-1,6-diyldipho...
Hexane-1,6-diyldiphosphonic acid (1,6-Hexanebisphosphonic acid) is a PROTAC linker based on the alkyl chain.